(Q43630883)

25 November 2017

title

Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection (English)

1 reference

high-performance liquid chromatography

25 November 2017

main subject

1 reference

Adrián LLerena

1

0 references

author name string

A Llerena

1

1 reference

25 November 2017

R Berecz

2

1 reference

25 November 2017

M J Norberto

3

1 reference

25 November 2017

A de la Rubia

4

1 reference

25 November 2017

Roland Berecz

2

0 references

Marı́a Jesús Norberto

3

0 references

Alfredo de la Rubia

4

0 references

publication date

1 May 2001

1 reference

Journal of Chromatography B: Biomedical Sciences and Applications

25 November 2017

May 2001

0 references

published in

1 reference

25 November 2017

volume

755

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

349-354

1 reference

describes a project that uses

25 November 2017

high-performance liquid chromatography

1 reference

Clinical profile of clozapine: adverse reactions and agranulocytosis

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Update on the clinical efficacy and side effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Pharmacokinetics and pharmacodynamics of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Automated determination of clozapine and major metabolites in serum and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900056-1

7 January 2021

10.1016/S0378-4347(01)00056-1

Identifiers

DOI

0 references

1 reference